Intravenous or localized injections of mesenchymal stem cells (MSCs) harvested from Wharton's jelly or bone marrow.
Aggressively targets systemic inflammation and dynamically repairs degraded joint, tendon, and organ tissue.
Operators travel to offshore clinics for multi-day IV infusions and direct joint injections.